The global market for pulmonary drug devices has gained substantially over the last few years and, with the alarming rise in the air pollution leading to the increased incidence rate of respiratory disorders, it is likely to maintain its growth at a high pace in the years to come.
View Research Report: http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Global Pulmonary Drug Delivery Devices Market is Expected to Progress at a CAGR of 3.30% between 2016 and 2024
1. Pulmonary Drug Delivery Devices Market
- Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2016 - 2024
The global pulmonary drug delivery devices market demonstrates a high
degree of competition between GlaxoSmithKline Plc, Boehringer
Ingelheim GmbH, AstraZeneca Plc, Teva Pharmaceutical Industries Ltd.,
and Merck & Co. Inc. states a new research report by Transparency
Market Research. With the top five players accounting for more than
67%, the market exhibits a largely consolidated structure.
Analysts project this market to remain competitive over the forthcoming
years, specifically the drug markets for asthma and chronic obstructive
pulmonary diseases (COPD), thanks to the robust product pipelines of
established drug-makers.
According to the research report, the worldwide market for pulmonary
drug delivery devices, which stood at US$32.2 bn in 2015, is expected to
progress at a CAGR of 3.30% between 2016 and 2024 and reach
US$43.05 bn by the end of the forecast period. The application of these
devices is higher in the asthma segment and is expected to remain so
over the next few years, thanks to the robust pipeline of drugs for the
treatment of asthma.
An analysis of the geographical presence of the global pulmonary drug
delivery devices market has also been presented in this research report.
As per the study, Europe, North America, Asia Pacific, Latin America,
and the Middle East and Africa are the prime regional markets for
2. pulmonary drug delivery devices. North America, among these, is
leading the global market with Europe trailing closely. The key factor
behind the rise of both the regional markets is the increasing prevalence
of COPD.
Browse Full Research Report on Pulmonary Drug Delivery Devices
Market: http://www.transparencymarketresearch.com/pulmonary-drug-
delivery-systems.html
With the technological advancements in pulmonary drug delivery
devices, North America is likely to retain its position across the world
with a share of more than 40% by the end of the forecast period. The
markets for pulmonary drug delivery devices in Asia Pacific, Latin
America, and the Middle East and Africa are also projected to witness
significant growth in the next few years, owing to the increasing
prevalence of respiratory disorders.
The rising level of awareness among consumers regarding health and
wellness and the increase in the disposable income are also anticipated
to propel these markets in the near future, states the research report.
“The rising pool of patients suffering from respiratory disorders is
having the most prominent impact on the global market for pulmonary
drug delivery devices,” states an analyst at TMR.
3. The alarming rise in air pollution and the increasing number of smokers,
worldwide, are adding substantially to the already worsened situation of
COPD patient pool, leading to a remarkable surge in the demand for
these devices. Analysts expect this scenario to remain so over the period
of forecast, resulting in a high demand pace for these devices.
In addition to this, the market is anticipated to benefit from the
increasing research and development in the treatments for asthma and
COPD in the near future. However, the imminent patent expiry of
blockbuster drugs and several regulatory hurdles may limit the growth of
this market to some extent in the years to come, notes the research study.
The study presented here is based on a report by Transparency Market
Research (TMR) titled “Pulmonary Drug Delivery Devices Market -
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,
2016 - 2024.”
Browse Full Press Release on Pulmonary Drug Delivery Devices
Market :
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants use
Press Release
4. proprietary data sources and various tools and techniques to gather and
analyze information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research material
for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com